VTYX(VTYX)
VTYX
ANALYST COVERAGE11 analysts
HOLD
▲ +0.0%upside to target
Key MetricsTTM
Market Cap$1.00B
Revenue TTM$0.00
Net Income TTM-$106.61M
Free Cash Flow-$87.87M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-48.1%
Return on Assets-50.4%
Debt / Equity0.05
Current Ratio17.86
EPS TTM$-1.50
PRICE
Prev Close
14.00
Open
14.00
Day Range—
52W Range0.78 – 25.00
0.78
25.00
55% of range
VOLUME & SIZE
Avg Volume
3.8M
FUNDAMENTALS
P/E Ratio
-9.4x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.35
Market-like
TECHNICAL
RSI (14)
80
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
PDividend Pay
In 96 days
Aug 25
VTYX News
About
No description available.
Sector
Industry
Medicinal and Botanical Manufacturing
Arline NakanishiSenior Vice President of Biometrics
Kathy OgilvieSenior Vice President of Translational & Nonclinical Research
Snehal NaikSenior Vice President of Clinical Development
John NussChief Scientific Officer
Mark S. FormanChief Medical Officer
Raju S. MohanFounder, Chief Executive Officer, President & Director
Sheila K. GujrathiExecutive Chairperson
Matthew Richard MooreChief Operating Officer
Roy GonzalesSenior Vice President of Finance and Principal Financial & Accounting Officer